Garber D W, Venkatachalapathi Y V, Gupta K B, Ibdah J, Phillips M C, Hazelrig J B, Segrest J P, Anantharamaiah G M
Atherosclerosis Research Unit, University of Alabama, Birmingham.
Arterioscler Thromb. 1992 Aug;12(8):886-94. doi: 10.1161/01.atv.12.8.886.
Peptide analogues of the class A amphipathic helixes from exchangeable apolipoproteins mimic apolipoprotein (apo) A-I in a number of ways, including the ability to activate the enzyme lecithin:cholesterol acyltransferase, to associate with high density lipoproteins (HDLs), and to form HDL-like particles in the presence of lipids. This study investigated the metabolic properties of several of these peptide analogues in the rat. Peptide analogues studied were 18A (referred to as L-18A to differentiate it from D-18A, and which mimics apolipoprotein amphipathic helical domains in its charge distribution), 37pA (a dimer of two 18A monomers separated by a proline), 18R (with reversed charge distribution compared with 18A), and D-18A (identical in amino acid sequence to 18A but synthesized from D-amino acids). Peptides were radiolabeled with 125I. In addition, metabolism of rat and human 125I-apo A-I and human 14C-apo A-I was studied; no significant differences in clearance of these preparations were seen. Clearance data were fitted to multiexponential equations to give half-times of clearance; biexponential equations consistently provided the best nonlinear least-squares curve fit. The order of relative lipid affinity determined in vitro was 37pA greater than apo A-I greater than D-18A = L-18A greater than 18R. Half-times of clearance were in the same approximate rank order: 37pA, 6.9 +/- 3.3 hours (mean +/- SD); apo A-I, 6.9 +/- 1.8 hours; D-18A, 4.0 +/- 1.0 hours; L-18A, 4.6 +/- 1.6 hours; and 18R, 0.9 +/- 0.1 hour.(ABSTRACT TRUNCATED AT 250 WORDS)
来自可交换载脂蛋白的A类两亲性螺旋的肽类似物在许多方面模拟载脂蛋白(apo)A-I,包括激活卵磷脂:胆固醇酰基转移酶的能力、与高密度脂蛋白(HDL)结合的能力以及在脂质存在下形成HDL样颗粒的能力。本研究调查了其中几种肽类似物在大鼠体内的代谢特性。所研究的肽类似物有18A(称为L-18A以区别于D-18A,其在电荷分布上模拟载脂蛋白两亲性螺旋结构域)、37pA(由脯氨酸隔开的两个18A单体的二聚体)、18R(与18A相比电荷分布相反)和D-18A(氨基酸序列与18A相同但由D-氨基酸合成)。肽用125I进行放射性标记。此外,还研究了大鼠和人125I-apo A-I以及人14C-apo A-I的代谢;这些制剂的清除率未见显著差异。清除率数据拟合到多指数方程以得出清除半衰期;双指数方程始终提供最佳的非线性最小二乘曲线拟合。体外测定的相对脂质亲和力顺序为37pA大于apo A-I大于D-18A = L-18A大于18R。清除半衰期大致处于相同顺序:37pA,6.9±3.3小时(平均值±标准差);apo A-I,6.9±1.8小时;D-18A,4.0±1.0小时;L-18A,4.6±1.6小时;18R,0.9±0.1小时。(摘要截断于250字)